Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats

Akaslan S. B., Degertekin C. K., Yilmaz G., Cakir N., Arslan M., TÖRÜNER F. S.

METABOLIC SYNDROME AND RELATED DISORDERS, cilt.11, sa.4, ss.243-250, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 4
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1089/met.2012.0128
  • Dergi Adı: METABOLIC SYNDROME AND RELATED DISORDERS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.243-250
  • Gazi Üniversitesi Adresli: Evet

Özet

Background: Studies investigating the effects of dipeptidyl peptidase-4 inhibitors on hepatic steatosis are lacking. We aimed to determine the effects of sitagliptin on nonalcoholic fatty liver disease (NAFLD) in rats with diet-induced obesity.